General Information of the Compound
Compound ID |
CP0386205
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[2-[[(4R,4aS,7S,7aR,12bS)-4a,10-dihydroxy-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-2-oxoethoxy]-N-[2-[3-[[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoylamino]phenoxy]ethyl]acetamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C46H49N7O9
|
||||||||||||||||||
Molecular Weight |
843.938
|
||||||||||||||||||
Canonical SMILES |
CN1CC[C@]23[C@H]4Oc5cc(O)cc(C[C@@H]1[C@]2(O)CC[C@@H]4NC(=O)COCC(=O)NCCOc1cccc(NC(=O)N[C@@H]2N=C(c4ccccc4)c4ccccc4N(C)C2=O)c1)c35
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C46H49N7O9/c1-52-19-17-45-39-28-21-30(54)24-35(39)62-41(45)33(15-16-46(45,59)36(52)22-28)49-38(56)26-60-25-37(55)47-18-20-61-31-12-8-11-29(23-31)48-44(58)51-42-43(57)53(2)34-14-7-6-13-32(34)40(50-42)27-9-4-3-5-10-27/h3-14,21,23-24,33,36,41-42,54,59H,15-20,22,25-26H2,1-2H3,(H,47,55)(H,49,56)(H2,48,51,58)/t33-,36+,41-,42-,45-,46+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
KWQBJVBPMDEZRS-ASKKFDEYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01124, Gastrin/cholecystokinin type B receptor
Protein ID: PT01515, Mu-type opioid receptor